Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide foam in active mild to moderate ulcerative proctitis or proctosigmoiditis
NCT01008423Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Nov 2009
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in ulcerative proctitis, ulcerative proctosigmoiditis, sponsored by Valeant Pharmaceuticals. Started Nov 2009; status: completed.
02
Drugs
budesonide
03
Conditions
ulcerative proctitisulcerative proctosigmoiditis
Beyond the preview
Go deeper on NCT01008423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008423.